SORLIS

Company Overview

Snapshot

Founded in July 2023 by Waseem Geraisy and Micha Nisani, SORLIS operates with 1–10 employees. The company has raised $500,000 across one funding round from Takwin. In February 2024, SORLIS secured seed funding, with Takwin participating.

Business overview

SORLIS is a Health Tech & Life Sciences company focused on transforming healthcare through the early detection and prevention of pressure ulcers. The company develops solutions designed to be impactful and practical for healthcare providers, aiming to alleviate patient suffering, streamline medical staff workflows, and reduce healthcare costs. By identifying pressure injuries at their onset, SORLIS seeks to establish new standards in patient care and efficiency within the healthcare system, operating primarily in the medical devices, diagnostics, and patient care sectors.

Company Intelligence Q&A

When was SORLIS founded?

SORLIS was founded in July 2023 by Waseem Geraisy and Micha Nisani.

What is SORLIS's primary focus?

SORLIS is dedicated to transforming healthcare through the early detection and prevention of pressure ulcers, aiming to improve patient care and operational efficiency for healthcare providers.

How much capital has SORLIS raised?

SORLIS has raised $500,000 across one funding round.

Which investor participated in SORLIS's seed funding round?

In February 2024, Takwin participated in SORLIS's seed funding round, which raised $500,000.

What problem does SORLIS aim to solve?

SORLIS aims to address the challenges of pressure ulcers by providing solutions for early detection, thereby reducing patient suffering, optimizing medical staff workflows, and lowering healthcare costs associated with preventable conditions.